CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

Kelly A. Sagar - Medical Cannabis Research Engine

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Kelly A. Sagar

OPENALEX: A5043280017↗ORCID: 0000-0002-4131-9259↗

Affiliations

Organizations

Boston Universityauthorship · US Cognitive Neuroimaging Labauthorship · FR Harvard Universityauthorship · US McLean Hospitalauthorship · US

Public evidence

3 connected articles

Clinical and Cognitive Improvement Following Treatment with a Hemp-Derived, Full-Spectrum, High-Cannabidiol Product in Patients with Anxiety: An Open-Label Pilot Study.2025 · Europe PMC Increased White Matter Coherence Following Three and Six Months of Medical Cannabis Treatment.2022 · PubMed Central Open Access Joint Effects: A Pilot Investigation of the Impact of Bipolar Disorder and Marijuana Use on Cognitive Function and Mood.2016 · PubMed Central Open Access

Matched by exact identifiers only. Profile data: Corpus/OpenAlex.